About Liniment Pharma Private Limited
Data last updated:
Liniment Pharma Private Limited is a private limited company based in Jaipur, Rajasthan, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24304RJ2018PTC060344. Its GSTIN is 08AADCL5328G1ZJ (Rajasthan).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.44 Lakh. It is led by directors Rohit Bafna and Aastha Dusad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. – 38 Shankar Colony Naya Kheda Ambabari, Jaipur, Rajasthan, India – 302039.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.64 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net loss of ₹12.04 Lakh (net margin -7.4%) and EBITDA of -₹11.5 Lakh (EBITDA margin -7%). Revenue has grown at a compounded annual rate (CAGR) of 54% over three years and 165% over five years.
The company has about 10 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: MEDdelivery. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 2 cases are pending. The company has 7 deals on record (3 funding rounds, 3 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹10.81 Cr; the latest was in August 2021. Its 10 peer companies in the same principal business activity (Services incidental to land, water & air transportation) are compared by revenue, 5 larger and 5 smaller; the largest is Seashuttle Private Limited with revenue of ₹1.66 Cr.
For more details, the company can be reached via its website meddelivery.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Apps
- Registered AddressPlot No. – 38 Shankar Colony Naya Kheda Ambabari, Jaipur, Rajasthan, India – 302039
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Liniment Pharma Private Limited
The main business activity of Liniment Pharma is transport and storage. In detail, this covers services incidental to land, water & air transportation.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| H | Transport and storage | H5 | Services incidental to land, water & air transportation | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Liniment Pharma Private Limited FY 2025 filings available
Liniment Pharma Private Limited reported revenue of ₹1.64 Cr (up 21% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Liniment Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 165% over five years, including 21% growth in the latest year. EBITDA rose 94% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Liniment Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹11.5 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹12.04 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Liniment Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -7.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Liniment Pharma are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Liniment Pharma Private Limited
Liniment Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Services incidental to land, water & air transportation). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Seashuttle Private Limited | ₹1.66 Cr (FY 2023) | •••• | •••• | 218.0% | •••• | Mumbai, Maharashtra, India |
| Aumn Globetech Private Limited | ₹1.65 Cr (FY 2025) | •••• | •••• | 75.0% | •••• | New Delhi, Delhi, India |
| Shreesai Trans Services Private Limited | ₹1.64 Cr (FY 2025) | •••• | •••• | 163.0% | •••• | Ranchi, Jharkhand, India |
| Vidhi Logistics Private Limited | ₹1.64 Cr (FY 2016) | •••• | •••• | -5.0% | •••• | Navi Mumbai, Maharashtra, India |
| Shearwater GLS Private Limited | ₹1.64 Cr (FY 2025) | •••• | •••• | 375.0% | •••• | Chennai, Tamil Nadu, India |
| Liniment Pharma Private Limited this company | ₹1.64 Cr (FY 2024) | •••• | •••• | 21.0% | •••• | Jaipur, Rajasthan, India |
| ZM Shipping and Logistics Private Limited | ₹1.63 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Thoothukudi, Tamil Nadu, India |
| RSL Container Lines Private Limited | ₹1.63 Cr (FY 2020) | •••• | •••• | 72.0% | •••• | Chennai, Tamil Nadu, India |
| Kottayam Port and Container Terminal Services Private Limited | ₹1.62 Cr (FY 2023) | •••• | •••• | -7.0% | •••• | Kottayam, Kerala, India |
| Across Roads Automobile Solutions Limited | ₹1.62 Cr (FY 2023) | •••• | •••• | -74.0% | •••• | New Delhi, Delhi, India |
| Penanshin Shipping India Private Limited | ₹1.62 Cr (FY 2024) | •••• | •••• | 165.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Liniment Pharma by revenue in the same principal business activity (Services incidental to land, water & air transportation), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Liniment Pharma Private Limited
Liniment Pharma Private Limited is audited by R SOGANI & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R SOGANI & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Liniment Pharma Private Limited
Liniment Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohit Bafna | Director | 26 Feb 2018 | 8 Years 7 Months | Current |
| Aastha Dusad Also directs: United Suppliers Solutions Private Limited | Director | 26 Feb 2018 | 8 Years 7 Months | Current |
Ownership and Shareholding of Liniment Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Liniment Pharma Private Limited
Liniment Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Liniment Pharma Private Limited
Liniment Pharma Private Limited has 7 deals on record (3 funding rounds, 3 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹10.81 Cr; the latest was in August 2021.
Deals on record (4 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Funding round · Seed | ₹96.5 Lakh | Investors: 4 individuals |
| Sep 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 4 individuals |
| Jun 2018 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
| May 2018 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
Full deal history
All 7 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Liniment Pharma Private Limited
Liniment Pharma Private Limited has 2 court cases on record: 1 filed by Liniment Pharma, 1 filed against it. All cases are pending. Status as checked between 21 Sep 2026 and 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Jaipur Metro I, Rajasthan | Court case (Rent Case) | Filed against the company by an individual | Pending |
| District court, Jaipur Metro I, Rajasthan | Court case (Rent Case) | Filed by the company against an individual | Pending |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Liniment Pharma Private Limited
Liniment Pharma operates one associated brand: MEDdelivery. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Retail pharma procurement is enabled via hyperlocal e-commerce platform. | meddelivery.in |
Employees and EPFO Compliance at Liniment Pharma Private Limited
Liniment Pharma Private Limited has a workforce of 10 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Liniment Pharma Private Limited
Liniment Pharma has 1 subsidiary company. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| United Suppliers Solutions Private Limited | U63031RJ2021PTC076980 | Locked |
Showing major subsidiaries. Total: 1.
Recent Activity on Liniment Pharma Private Limited
Liniment Pharma Private Limited has 6 board changes on record since 2018: 2 appointments and 4 cessations. The latest: Rahul Gautam ceased to be Additional Director on 13 Feb 2020.
Credit Ratings, Litigation & Regulatory Alerts for Liniment Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Liniment Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Liniment Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Liniment Pharma Private Limited
Liniment Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AADCL5328G1ZJ | Rajasthan | Active | 08 Jan 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Liniment Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Liniment Pharma Private Limited
Liniment Pharma is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 February 2018 (8+ years old) and is registered under CIN U24304RJ2018PTC060344.
Liniment Pharma reported revenue of ₹1.64 Cr for FY 2024 (up 21% YoY).
Liniment Pharma has 2 current directors:
- Rohit Bafna - Director
- Aastha Dusad - Director
Liniment Pharma reported a net loss of ₹12.04 Lakh (net margin -7.4%) and EBITDA of -₹11.5 Lakh (EBITDA margin -7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Liniment Pharma is 54% over three years and 165% over five years. In the latest year (FY 2024) revenue rose 21%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Liniment Pharma is 08AADCL5328G1ZJ, registered in Rajasthan.
The CIN (Corporate Identification Number) of Liniment Pharma is U24304RJ2018PTC060344. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Liniment Pharma has 2 court cases on record: 1 filed by the company and 1 filed against it. 2 are pending.
Liniment Pharma was incorporated on 26 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Jaipur.
Liniment Pharma has 7 deals on record (3 funding rounds, 3 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹10.81 Cr; the latest was in August 2021.
The peers of Liniment Pharma by revenue are Seashuttle Private Limited, Aumn Globetech Private Limited, Shreesai Trans Services Private Limited, Vidhi Logistics Private Limited, Shearwater GLS Private Limited and 5 more, all in the same principal business activity (Services incidental to land, water & air transportation).